申请人:G. D. Searle & Co.
公开号:US04923891A1
公开(公告)日:1990-05-08
This invention encompasses compounds of Formula I ##STR1## and the pharmaceutically acceptable salts and geometrical and optical isomers thereof wherein: X, Y, and Z are each independently O or S with S optionally oxidized to S=O; Alk is straight or branched chain alkylene or hydroxyalkylene containing 1-6 carbon atoms; R.sub.1 is hydrogen or lower alkyl; n is 0 to 5; R.sub.2 is hydrogen, lower alkyl, cycloalkyl, --(CH.sub.2).sub.n --CO.sub.2 R.sub.1, phenyl, phenyl substituted with halo, lower alkyl or lower alkoxy; and Ar is 5,6,7,8-tetrahydro-1-naphthalenyl, phenyl, or phenyl substituted with lower alkyl, hydroxy, lower alkoxy, or lower alkanoyl. This invention is in the field of pharmaceutical agents which act as leukotriene D.sub.4 (LTD.sub.4) antagonists and includes embodiments which act as leukotriene B.sub.4 (LTD.sub.4) antagonists.
这项发明涵盖了Formula I的化合物##STR1##及其药用可接受的盐和几何和光学异构体,其中:X、Y和Z分别独立地为O或S,其中S可氧化为S=O;Alk为含有1-6个碳原子的直链或支链烷基或羟基烷基;R.sub.1为氢或较低的烷基;n为0至5;R.sub.2为氢、较低的烷基、环烷基、--(CH.sub.2).sub.n --CO.sub.2 R.sub.1、苯基、苯基取代物与卤素、较低烷基或较低烷氧基;Ar为5,6,7,8-四氢-1-萘基、苯基或苯基取代物与较低烷基、羟基、较低烷氧基或较低烷酰基。这项发明涉及作为白三烯D.sub.4(LTD.sub.4)拮抗剂的药用剂,包括作为白三烯B.sub.4(LTD.sub.4)拮抗剂的实施形式。